Scallan, E, et al.
Foodborne illness acquired in the United States – major pathogens. Emerging Infectious Diseases
2011; 17: 7–15.
Havelaar, AH, et al.
Disease burden of foodborne pathogens in the Netherlands, 2009. International Journal of Food Microbiology
2012: 156: 231–238.
Lake, RJ, et al.
Risk ranking for foodborne microbial hazards in New Zealand: burden of disease estimates. Risk Analysis
2010; 30: 743–752.
Murray, CJ, Lopez, AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet
1997; 349: 1436–1442.
Havelaar, AH, Kemmeren, JM, Kortbeek, LM. Disease burden of congenital toxoplasmosis. Clinical Infectious Diseases
2007; 44: 1467–1474.
Havelaar, AH, et al.
Prioritizing emerging zoonoses in the Netherlands. PLoS ONE
2010; 5: e13965.
Kemmeren, JM, et al.
Priority setting of foodborne pathogens: disease burden and costs of selected enteric pathogens. Bilthoven: National Institute of Public Health and Environment, 2006
Gastanaduy, PA, et al.
Burden of norovirus gastroenteritis in the ambulatory setting – United States, 2001–2009. Journal of Infectious Diseases
2013; 207: 1058–1065.
Guerina, NG. Congenital infection with Toxoplasma gondii. Pediatric Annals
1994; 23: 138–142, 147–151.
Alford, CA Jr., Stagno, S, Reynolds, DW. Congenital toxoplasmosis: clinical, laboratory, and therapeutic considerations, with special reference to subclinical disease. Bulletin of the New York Academy of Medicine
1974; 50: 160–181.
Kimball, AC, Kean, BH, Fuchs, F. Congenital toxoplasmosis: a prospective study of 4,048 obstetric patients. American Journal of Obstetrics and Gynecology
1971; 111: 211–218.
World Health Organization. Toxoplasmosis, Technical Report Series, No. 431. Geneva: World Health Organization, 1969.
Cook, AJ, et al.
Sources of toxoplasma infection in pregnant women: European multicentre case-control study. European Research Network on Congenital Toxoplasmosis. British Medical Journal
2000; 321: 142–147.
Tam, CC, et al.
Incidence of Guillain-Barre syndrome among patients with Campylobacter infection: a general practice research database study. Journal of Infectious Diseases
2006; 194: 95–97.
Ternhag, A, et al.
Short- and long-term effects of bacterial gastrointestinal infections. Emerging Infectious Diseases
2008; 14: 143–148.
McCarthy, N, Giesecke, J. Incidence of Guillain-Barre syndrome following infection with Campylobacter jejuni. American Journal of Epidemiology
2001; 153: 610–614.
Helms, M, Simonsen, J, Molbak, K. Foodborne bacterial infection and hospitalization: a registry-based study. Clinical Infectious Diseases
2006; 42: 498–506.
Frenzen, PD. Hospital admissions for Guillain-Barre syndrome in the United States, 1993–2004. Neuroepidemiology
2007; 29: 83–88.
Gould, LH, et al.
Hemolytic uremic syndrome and death in persons with Escherichia coli O157: H7 infection, foodborne diseases active surveillance network sites, 2000–2006. Clinical Infectious Diseases
2009; 49: 1480–1485.
Garg, AX, et al.
Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: a systematic review, meta-analysis, and meta-regression. Journal of the American Medical Association
2003; 290: 1360–1370.
Haagsma, JA, et al.
Disease burden of post-infectious irritable bowel syndrome in The Netherlands. Epidemiology and Infection
2010; 138: 1650–1656.
Hannu, T, et al.
Campylobacter-triggered reactive arthritis: a population-based study. Rheumatology (Oxford)
2002; 41: 312–318.
Raybourne, RB, Roberts, T, Williams, KM. Food poisoning: economic implications. In: Caballero, B, Trugo, L, Finglas, P, eds. Encyclopedia of Food Sciences & Nutrition. London, UK: Elsevier Science, 2003.
Townes, JM, et al.
Reactive arthritis following culture-confirmed infections with bacterial enteric pathogens in Minnesota and Oregon: a population-based study. Annals of the Rheumatic Diseases
2008; 67: 1689–1696.
Mylonakis, E, et al.
Listeriosis during pregnancy: a case series and review of 222 cases. Medicine (Baltimore)
2002; 81: 260–269.
Bowie, WR, et al.
Outbreak of toxoplasmosis associated with municipal drinking water. The BC Toxoplasma Investigation Team. Lancet
1997; 350: 173–177.
Jones, JL, Holland, GN. Annual burden of ocular toxoplasmosis in the US. American Journal of Tropical Medicine and Hygiene
2010; 82: 464–465.
Haagsma, JA, et al.
Disability adjusted life years and minimal disease: application of a preference-based relevance criterion to rank enteric pathogens. Population Health Metrics
2008; 6: 7.
Sobel, J, et al.
Necrotizing enterocolitis associated with clostridium perfringens type A in previously healthy north American adults. Journal of the American College of Surgeons
2005; 201: 48–56.
Bos, J, et al.
Fatal necrotizing colitis following a foodborne outbreak of enterotoxigenic Clostridium perfringens type A infection. Clinical Infectious Diseases
2005; 40: e78–83.
Centers for Disease Control and Prevention. Fatal foodborne Clostridium perfringens illness at a state psychiatric hospital – Louisiana, 2010. Morbidity and Mortality Weekly Report
2012; 61: 605–608.
Hall, AJ, et al.
The roles of Clostridium difficile and norovirus among gastroenteritis-associated deaths in the United States, 1999–2007. Clinical Infectious Diseases
2012; 55: 216–223.
Centers for Disease Control and Prevention. Vital signs: incidence and trends of infection with pathogens transmitted commonly through food – Foodborne Diseases Active Surveillance Network, 10 U.S. sites, 1996–2010. Morbidity and Mortality Weekly Report
2011; 60: 749–755.
Jung, IS, et al.
The clinical course of postinfectious irritable bowel syndrome: a five-year follow-up study. Journal of Clinical Gastroenterolgy
2009; 43: 534–540.
Jones, JL, et al.
Toxoplasma gondii infection in the United States, 199 92 004, decline from the prior decade. American Journal of Tropical Medicine and Hygiene
2007; 77: 405–410.
Jones, JL, et al.
Risk factors for Toxoplasma gondii infection in the United States. Clinical Infectious Diseases
2009; 49: 878–884.
Jones, JL, Dubey, JP. Foodborne toxoplasmosis. Clinical Infectious Diseases
2012; 55: 845–851.
Mertz, HR. Irritable bowel syndrome. New England Journal of Medicine
2003; 349: 2136–2146.
Hungin, AP, et al.
The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40 000 subjects. Alimentary Pharmacology and Therapeutics
2003; 17: 643–650.
Spiller, R. Role of infection in irritable bowel syndrome. Journal of Gastroenterology
2007; 42 (Suppl.) 17: 41–47.
Hoffmann, S, Batz, MB, Morris, JG Jr.. Annual cost of illness and quality-adjusted life year losses in the United States due to 14 foodborne pathogens. Journal of Food Protection
2012; 75: 1292–1302.
Scharff, RL. Economic burden from health losses due to foodborne illness in the United States. Journal of Food Protection
2012; 75: 123–131.
Garcia Rodriguez, LA, Ruigomez, A, Panes, J. Acute gastroenteritis is followed by an increased risk of inflammatory bowel disease. Gastroenterology
2006; 130: 1588–1594.
Zanini, B, et al.
Incidence of post-infectious irritable bowel syndrome and functional intestinal disorders following a water-borne viral gastroenteritis outbreak. American Journal of Gastroenterology
2012; 107: 891–899.